Contextual immersion trading strategy idea. Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases The demand for shares of the company looks higher than the supply. Due to the spread of COVID-19, the demand for the company`s services rose. This and...
• CDTX • Entry: 3.61 • Stop loss: 3.20 (-11.35%) • Profit target 1: 4.36 (20.77%)
Stock has formed a very strong base and in a very strong uptrend, looks very healthy for more possible gains
CDTX: Cidara Therapeutics, Inc. 2018-09-25 08:00:00 FDA Grants QIDP and Fast Track Designations to Cidara Therapeutics’ Rezafungin Prophylaxis Development Program
CDTX - Looking for a break above 4.73. Possible fallen angel with possible longer term rally potential to 7.83.
Phase 2 trial results due anytime now. Watching for levels where CEO and CMO have been buying to potentially get in.
CDTX can reach to there 200 MA , good news on the way .